Cerebral Small Vessel Disease, Risk Factors, and Cognition in Tenants of Precarious Housing

Supplemental Digital Content is available in the text. Background and Purpose: We aim to describe the burden, characteristics, and cognitive associations of cerebral small vessel disease in a Canadian sample living with multimorbidity in precarious housing. Methods: Participants received T1, T2-fluid-attenuated inversion recovery, and susceptibility-weighted imaging 3T magnetic resonance imaging sequences and comprehensive clinical, laboratory, and cognitive assessments. Cerebral small vessel disease burden was characterized using a modified Small Vessel Disease (mSVD) score. One point each was given for moderate-severe white matter hyperintensities, ≥1 cerebral microbleeds, and ≥1 lacune. Multivariable regression explored associations between mSVD score, risk factors, and cognitive performance. Results: Median age of the 228 participants (77% male) was 44.7 years (range, 23.3–63.2). In n=188 participants with consistent good quality magnetic resonance imaging sequences, mSVD scores were 0 (n=127, 68%), 1 (n=50, 27%), and 2 (n=11, 6%). Overall, one-third had an mSVD ≥1 n=61 (32%); this proportion was unchanged when adding participants with missing sequences n=72/228 (32%). The most prevalent feature was white matter hyperintensities 53/218 (24%) then cerebral microbleed 16/191 (8%) and lacunes 16/228 (7%). Older age (odds ratio, 1.10 [95% CI, 1.05–1.15], P<0.001), higher diastolic blood pressure (odds ratio, 1.05 [95% CI, 1.01–1.09], P=0.008), and a history of injection drug use (odds ratio, 3.13 [95% CI, 1.07–9.16], P=0.037) had significant independent associations with a mSVD score of ≥1 in multivariable analysis. mSVD ≥1 was associated with lower performance on tests of verbal memory, sustained attention, and decision-making, contributing 4% to 5% of the variance in each cognitive domain. Conclusions: The 32% prevalence of cerebral small vessel disease in this young, socially marginalized cohort was higher than expected for age and was associated with poorer cognitive performance.

[1]  Thalia Shoshana Field,et al.  Prevalence and Risk Factors of Brain Infarcts and Associations With Cognitive Performance in Tenants of Marginal Housing , 2019, Journal of the American Heart Association.

[2]  E. Wood,et al.  Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. , 2018, Drug and alcohol dependence.

[3]  R. Tubiana,et al.  Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy–Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Terence J. Quinn.  Vascular cognitive impairment , 2018, Nature Reviews Disease Primers.

[5]  J. Biller,et al.  Total cerebral small vessel disease score and cognitive performance in community‐dwelling older adults. Results from the Atahualpa Project , 2018, International journal of geriatric psychiatry.

[6]  Thalia Shoshana Field,et al.  Traumatic Brain Injury in a Community-Based Cohort of Homeless and Vulnerably Housed Individuals. , 2017, Journal of neurotrauma.

[7]  T. Noguchi,et al.  Total Small Vessel Disease Score in Neurologically Healthy Japanese Adults in the Kashima Scan Study , 2017, Internal medicine.

[8]  David C. Anderson,et al.  Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions , 2017, Annals of neurology.

[9]  P. Rothwell,et al.  Total small vessel disease score and risk of recurrent stroke , 2017, Neurology.

[10]  Federica Scarpina,et al.  The Stroop Color and Word Test , 2017, Front. Psychol..

[11]  Thalia Shoshana Field,et al.  Early life characteristics and late life burden of cerebral small vessel disease in the Lothian Birth Cohort 1936 , 2016, Aging.

[12]  I. Deary,et al.  Total MRI load of cerebral small vessel disease and cognitive ability in older people , 2015, Neurobiology of Aging.

[13]  C. Strassburg,et al.  Cerebral white matter lesions in patients with cirrhosis – causative for hepatic encephalopathy or bystanders? , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Richard Frayne,et al.  Early Cerebral Small Vessel Disease and Brain Volume, Cognition, and Gait , 2015, Annals of neurology.

[15]  Joanna M. Wardlaw,et al.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.

[16]  I. Deary,et al.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.

[17]  David C. Anderson,et al.  Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[18]  W. Honer,et al.  The hotel study: multimorbidity in a community sample living in marginal housing. , 2013, The American journal of psychiatry.

[19]  Andreas Charidimou,et al.  MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  A. Gadermann,et al.  Substance Use and Access to Health Care and Addiction Treatment among Homeless and Vulnerably Housed Persons in Three Canadian Cities , 2013, PloS one.

[21]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[22]  N. Scarmeas,et al.  Diet and Neuroimaging Markers of Cerebrovascular Disease , 2013, Current Nutrition Reports.

[23]  T. Aubry,et al.  The health and housing in transition study: a longitudinal study of the health of homeless and vulnerably housed adults in three Canadian cities , 2011, International Journal of Public Health.

[24]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[25]  T. Krings,et al.  Addictive Illegal Drugs: Structural Neuroimaging , 2010, American Journal of Neuroradiology.

[26]  D. Werring,et al.  The Microbleed Anatomical Rating Scale (MARS) , 2009, Neurology.

[27]  Melissa T. Buelow,et al.  Construct Validity of the Iowa Gambling Task , 2009, Neuropsychology Review.

[28]  E. V. van Dijk,et al.  Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.

[29]  B. Christensen,et al.  Measuring premorbid IQ in traumatic brain injury: An examination of the validity of the Wechsler Test of Adult Reading (WTAR) , 2008, Journal of clinical and experimental neuropsychology.

[30]  Hugh S Markus,et al.  Risk factor profile of cerebral small vessel disease and its subtypes , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  M. Tyndall,et al.  The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver , 2006 .

[32]  D. Meltzer,et al.  Use of a Self-Report-Generated Charlson Comorbidity Index for Predicting Mortality , 2005, Medical care.

[33]  R. Riascos,et al.  Neuroimaging in Drug and Substance Abuse Part II: Opioids and Solvents , 2005, Topics in magnetic resonance imaging : TMRI.

[34]  R. Riascos,et al.  Neuroimaging in Drug and Substance Abuse Part I: Cocaine, Cannabis, and Ecstasy , 2005, Topics in magnetic resonance imaging : TMRI.

[35]  K. Skullerud,et al.  Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. , 1999, Forensic science international.

[36]  T. Robbins,et al.  CANTAB battery: proposed utility in neurotoxicology. , 1996, Neurotoxicology and teratology.

[37]  A. Damasio,et al.  Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.

[38]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[39]  A. E. Bateman.  The Statistics of Canada , 1878 .

[40]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.